title: Safety and immunogenicity of hepatitis B vaccine regimens in adults with HIV-1.
authors.forename: Laurent
authors.initials: L
authors.lastname: Bélec
authors.forename: François-Jérome
authors.initials: FJ
authors.lastname: Authier
authors.forename: Romain K
authors.initials: RK
authors.lastname: Gherardi
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects*; D000536:Aluminum Hydroxide / Q000008:administration & dosage / Q000009:adverse effects*; D003072:Cognition Disorders / Q000139:chemically induced; D005221:Fatigue / Q000139:chemically induced; D015658:HIV Infections / Q000150:complications; D006509:Hepatitis B / Q000150:complications / Q000517:prevention & control; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007271:Injections, Intradermal; D007273:Injections, Intramuscular; D010146:Pain / Q000139:chemically induced; D013577:Syndrome
chemical_list: D000276:Adjuvants, Immunologic; D017325:Hepatitis B Vaccines; D000536:Aluminum Hydroxide